Plus de 40 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline (CAREMIBRAIN)
Date du début: 1 juin 2016, Date de fin: 31 mai 2019,
...of organ-dedicated PET systems. Our company submits the present business innovation project with the overall objectives of (1) marketing an innovative brain-dedicated PET system to early diagnosis of Alzheimer’s disease (AD) and other causes of cognitive decline based on the detection of amyloid-β biomarker in the brain using three 18F-labelled tracers recently approved by FDA and EMEA (Florbetapi ...
Voir le projet
1
Participant partenaire
TERMINÉ
Prospective Memory in Mild Cognitive Impairment (PMINMCI)
Date du début: 1 oct. 2014, Date de fin: 31 mars 2016,
...ent lives and preserve well being into old age. To address this pressing issue, PMinMCI will conduct the first systematic and innovative investigation of prospective memory in older adults at risk of Alzheimer’s disease. Prospective memory refers to remembering to do things in future (e.g., remembering to take medication or pay bills on time). Although it is a vitally important skill for one to fu ...
Voir le projet
2
Participants partenaires
TERMINÉ
A new brain-dedicated Positron Emission Tomography (PET) system to identify β-amyloid biomarker for the early diagnosis of Alzheimer’s disease and other causes of cognitive decline (CAREMiBRAIN)
Date du début: 1 oct. 2014, Date de fin: 31 mars 2015,
...rcialisation of organ-dedicated PET systems. Our company submits the present innovation project with the overall objectives of marketing an innovative brain-dedicated PET system to early diagnosis of Alzheimer’s disease (AD) based on the detection of β-amyloid biomarker in the brain using two 18F-labelled tracers recently approved by FDA and EMEA for their clinical use and a validation of the clin ...
Voir le projet
1
Participant partenaire
TERMINÉ
European Prevention of Alzheimer’s Dementia Consortium (EPAD)
Date du début: 1 janv. 2015, Date de fin: 31 déc. 2019,
Background:The secondary prevention of Alzheimer’s dementia (AD) is achievable if we can identify individuals at risk of disease progression defined by biomarker evidence of AD pathology and no or only minimal clinical symptoms and engage them in a standing adaptive clinical trial, of the highest quality, testing multiple interventions. To achieve this, EPAD will also provide the analytical infras ...
Voir le projet
40
Participants partenaires
TERMINÉ
Emulsar: give the world appetite for health. (GWAFH)
Date du début: 1 févr. 2015, Date de fin: 31 juil. 2015,
...ith enhanced taste on the market.The combination of aging populations, more sedentary lifestyles and poor nutrition habits has created a huge raise in public health issues such as diabetes, obesity, Alzheimer, denutrition and cancer. Health goes through nutrition.Today, poor taste is one of the main criticisms heard about healthy functional food, and undoubtedly the major reason for poor consumpt ...
Voir le projet
1
Participant partenaire
TERMINÉ
Alzheimer’s Disease Diagnosis by Spectroscopy. Accurate and Non-Invasive Medical Device for the Diagnosis of Early Stage Alzheimer's Disease. (ADiRaS)
Date du début: 1 juil. 2015, Date de fin: 31 oct. 2015,
Raman HT is a company expert on Raman Spectroscopy (RS) which has developed a revolutionary medical device to diagnose Alzheimer’s Disease (AD) in blood plasma for the first time. Currently, there are only two accurate methods to diagnose AD, expensive, invasive with multiple side effects. Positron Emission Tomography (PET) scans the patient’s brain after being injected with a radioactive marker ( ...
Voir le projet
1
Participant partenaire
TERMINÉ
Investigating the impact of meditation training on mental health and wellbeing in the ageing population (MEDIT-AGEING)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2020,
As the number of older people in Europe grows, increasing healthy life years is a priority. Cognitive decline, dementia (e.g. Alzheimer’s disease, AD), sleep disturbances and depression, all related to psychological distress and anxiety, are significant drivers of reduced quality of life in older adults. This project builds on evidence that lifestyle factors and meditation practice have the potent ...
Voir le projet
12
Participants partenaires
TERMINÉ
implementAtion anD OPeration of the gateway for healTh into BBMRI-ERIC (ADOPT BBMRI-ERIC)
Date du début: 1 oct. 2015, Date de fin: 30 sept. 2018,
...er implementation", reflecting the targets of the European Research Area (ERA). One of the challenges in the post-genomic era is the research on common complex diseases, such as cancer, diabetes and Alzheimer’s disease. Revealing these diseases will depend critically on the study of human biological samples and data from large numbers of patients and healthy individuals. The EU’s ageing populatio ...
Voir le projet
22
Participants partenaires
TERMINÉ
Data-driven models for Progression Of Neurological Disease (EuroPOND)
Date du début: 1 janv. 2016, Date de fin: 31 déc. 2019,
...ment of new evidence-based treatments in Europe through deeper disease understanding, better patient stratification for clinical trials, and improved accuracy of diagnosis and prognosis. For example, Alzheimer’s disease alone costs European citizens around €200B every year in care and loss of productivity. No disease modifying treatments are yet available. Clinical trials repeatedly fail because d ...
Voir le projet
9
Participants partenaires
TERMINÉ
Validation of a fast and simple peripheral blood diagnostic biomarker kit for Alzheimer’s disease (ADDIA)
Date du début: 1 août 2015, Date de fin: 31 juil. 2018,
The French SME Amoneta Diagnostics has previously developed a diagnostic kit for Alzheimer’s disease (AD) based on two blood biomarkers that are scientifically proven to be associated with AD. The company holds the intellectual property for specific fluorescent probes that can detect these biomarkers in small amounts of blood using flow cytometry. Currently, no single test to diagnose AD exists. A ...
Voir le projet
1
Participant partenaire
TERMINÉ
Synaptic dysfunction in Neurodegenerative Diseases (SYNDEGEN)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
...iseases (NDDs) of aging are a growing burden on societies. Although studies on the degeneration of neurons have been a main focus of research, increasing evidence points to synapses as the site where Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD) begin. There is growing evidence that synapses are sites of early and aberrant protein misfolding, aggregation and spre ...
Voir le projet
8
Participants partenaires
TERMINÉ
Magnetic DIagnostic Assay for neurodegenerative diseases (MADIA)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2019,
...icles (MNPs) and advanced bio-chemical functionalization methods for the early and ultrasensitive in vitro detection of biomarkers trustfully associated with 2 incurable neurodegenerative diseases: Alzheimer’s Disease (AD) and Parkinson Disease (PD). We plan to achieve sensitivities at least three orders of magnitude higher than best state-of-the-art values flexibility to operate for a wide range ...
Voir le projet
10
Participants partenaires
TERMINÉ
Bendable Bioplatform for Electrically stimulated Neuronal Differentiation (BEND)
Date du début: 15 août 2016, Date de fin: 14 août 2018,
... Proposal for H2020-MSCA-IF-2015 “Bendable Bioplatform for Electrically stimulated Neuronal Differentiation”With western countries aging faster, the neurodegenerative diseases like Parkinson’s, Alzheimer’s, Huntington’s etc. pose serious threat to quality of life, especially for people over 65 years[1]. In Europe, number of people suffering with dementia, which results from neuronal degeneration, ...
Voir le projet
1
Participant partenaire
TERMINÉ
Blood Biomarker-based Diagnostic Tools for Early Stage Alzheimer’s Disease (BBDiag)
Date du début: 1 janv. 2017, Date de fin: 31 déc. 2020,
Alzheimer’s disease (AD) affects more than 7 million people in Europe and this figure is expected to double every 20 years. Despite intensive efforts, no disease-modifying treatments or preventive strategies are available. The lack of specific, sensitive and minimally invasive diagnostics to identify people with early-stage AD to be included in clinical drug intervention trials is among the main r ...
Voir le projet
13
Participants partenaires
TERMINÉ
Grammar and memory: Evidence from agrammatic aphasia and probable Alzheimer's disease in German, Italian and Greek (MemoGram)
Date du début: 1 sept. 2013, Date de fin: 31 août 2015,
"In Europe, there is an increasing number of people with neurological problems, such as probable Alzheimer’s disease (pAD) or aphasia, which often result in severe language and memory impairments. It has been argued that memory deficits contribute to the language problems brain-damaged populations face and, further, can predict these populations’ patterns of linguistic impairment. Interestingly, w ...
Voir le projet
1
Participant partenaire
TERMINÉ
Connecting neuronal network activity with regional specificity for Alzheimer pathology: a multi-modal neuroimaging approach (CONNECT)
Date du début: 1 mars 2017, Date de fin: 28 févr. 2019,
As the world’s population is aging, the prevalence of Alzheimer’s disease (AD) is estimated to triple by 2050. Even though AD was identified more than 100 years ago, research has gained momentum only the last 30 years. To date, studies have mainly focused on the accumulation of two proteins, amyloid-beta and tau to understand the pathophysiology of this disease. In this project, I will take a new ...
Voir le projet
1
Participant partenaire
TERMINÉ
"Hepimiz Geleceğin Yaşlısıyız"
Date du début: 1 oct. 2016, Date de fin: 30 sept. 2017,
Why we prepared this Project: the Project is developed to create solution for the memory disorders that Alzheimer or Dementia cause. In this case; we start out to set a course for the problems, which our staff, students, and nursing staff at home face. In this frame, the project will be contributive to employment of the students who participate to our project through the healthy aging and welfare ...
Voir le projet
3
Participants partenaires
TERMINÉ
Care for Carers
Date du début: 1 oct. 2016, Date de fin: 30 sept. 2018,
...uits their time availability as well as their individual learning needs and style, through a blended learning interactive portal.It is estimated that by 2040, 14 million Europeans will be affected by Alzheimer’s disease, costing about €140 billion in care each year. It is anticipated that these figures for dementia will double every 20 years (Máire Geoghegan-Quinn Irish European Commissioner for R ...
Voir le projet
6
Participants partenaires
TERMINÉ
Development of a Training Program for the Improvement of Quality of Life of Persons with Alzheimer through “Serious Games”
Date du début: 1 sept. 2016, Date de fin: 31 août 2018,
Worldwide, there is about 24 million Alzheimer's patients, 6 million in Europe, affecting 10% of the population over 65 and nearly 50% of those over 85. This disease affects not only the individual but also their families and caregivers.Therapies based on "SERIOUS GAMES" to stimulate cognitive abilities of Persons with Alzheimer (PwA) are exhibiting good results when they are used with persons wi ...
Voir le projet
6
Participants partenaires
TERMINÉ
Alzheimer'ı UNUTMA
Date du début: 1 sept. 2016, Date de fin: 31 août 2017,
...ly Care of Ataturk Vocational and Technical Anatolian High School in Erzincan. Our project has been planned to be implemented in 2 flows.-1st flow: It will be implemented with respect to the 'Care of Alzheimer patients' by the Ataturk Vocational and Technical Anatolian High School between 06.03.2017 and 21.03.2017, in cooperation with Ikafalvi Farkas Bela Reformatus Idösek institution located in B ...
Voir le projet
2
Participants partenaires
TERMINÉ
INtgenerational and inTERcultural interACTion promotes social inclusion and solidarity
Date du début: 1 août 2016, Date de fin: 31 juil. 2018,
...tified on the territory where the Cooperative operates to reach two specific objectives. The first is to promote the intergenerational dialogue allowing the INTERACTion between youth and elderly with Alzheimer -or other cognitive problems- proposing also new innovative activities. This will include fostering the interaction between elderly people and the other users of the Cooperative’s centres, a ...
Voir le projet
4
Participants partenaires
TERMINÉ
DESARROLLO DE LA CONSCIENCIA E IMPORTANCIA DEL MERCADO GLOBAL EUROPEO PARA EL ALUMNADO DE GRADO MEDIO
Date du début: 1 juil. 2016, Date de fin: 30 juin 2017,
...e, Social-og Sundhedsskolen Federicia Veije Horsens in Denmark and San Giovanni Bosco in Viadana, Italy. The intermediary company, Centro Studi cultura Sviluppo in Pistoia, Italy and with the Irish Alzheimer Association in Dublin, Ireland. - 2nd professional field. Industrial area. Here we have two courses, “Mechanized Production”, and “Industrial Maintenance”. In those cases we work with the voca ...
Voir le projet
9
Participants partenaires
TERMINÉ
Volunteering to promote Solidarity Between Generations
Date du début: 1 janv. 2016, Date de fin: 31 août 2017,
... Rifugio Re Carlo Alberto. The centre, based in Luserna San Giovanni (a small town near Turin) hosts several elderly people with variable degrees of self-sufficiency and people suffering from the Alzheimer disease. There, the volunteers will have a supporting role of the local staff, as creative resource, in the daily activities carried out. Those activities will range from the ones of supporting ...
Voir le projet
4
Participants partenaires
TERMINÉ
Home Based Care - Home Based Education
Date du début: 1 sept. 2015, Date de fin: 31 août 2017,
Context: The population of Europe is getting older. As the propensity to be diagnosed with Alzheimer's or other dementias increases with age, the number of people who will be diagnosed with Alzheimer's or other dementias is set to increase in the foreseeable future. There is no cure for Alzheimer's or other dementias. The provision of care to people with dementia is costly to states around Europ ...
Voir le projet
3
Participants partenaires
TERMINÉ
Move For Social Inclusion
Date du début: 1 sept. 2014, Date de fin: 1 nov. 2015,
...perience for 9 months, in the Rifugio Re Carlo Alberto hosting organization, in Italy.
The centre hosts several elderly people with variable degrees of self-sufficiency and people suffering from the Alzheimer disease. There, the volunteers had a supporting role of the local staff, as creative resource, in the daily activities carried out. Those activties ranged from the ones of supporting social ...
Voir le projet
5
Participants partenaires
TERMINÉ
Digital timelines
Date du début: 1 sept. 2014, Date de fin: 31 août 2016,
...is estimated that there are currently 1.04 million (1.65%) sufferers in the UK, 270,300 (1.26%) in Romania, , 32,000 (1.57%) in Slovenia, 331,000 (0.44%) in Turkey and 173,000 (1.82%) in Sweden. (Alzheimer Europe 2012 stats) There are more than 10 million across Europe and 44 million globally. Directly linked to longevity, this is set to double over the next 20 years. Until, indeed if, dementia be ...
Voir le projet
6
Participants partenaires
TERMINÉ
... The consortium is formed by partners well-known at national level, with a wide experience in working with and training elderly carers, and members of European networks in the elderly care field (Alzheimer Europe, Eurocarers, Age Platform). The main products of the ELMI project will be the e-learning tool adapted to Romania's needs, the on-line platform of resources for family carers, the ECVET ag ...
Voir le projet
7
Participants partenaires
TERMINÉ
Label Free Nanoscopy Using Infra Red (LANIR)
Date du début: 1 avr. 2012, Date de fin: 30 sept. 2015,
Every year, Alzheimer's disease (AD) affects about 800,000 new patients in Europe and directly causes 50% of dependency of aged persons. Currently there is no test to diagnose this disease. There is a great need to improve outcomes for patients with lung cancer which causes between 15-28% of all cancer deaths in Europe.Chemical and structural imaging with nanoresolution under ambient conditions ca ...
Voir le projet
11
Participants partenaires
TERMINÉ
Neurobiological Mechanisms of Memory Loss in Alzheimer's Disease (MEMOLOAD)
Date du début: 1 févr. 2008, Date de fin: 31 juil. 2013,
"The MEMOLOAD project will focus on the molecular and biological mechanisms underlying memory loss that occurs in Alzheimer’s disease, the leading cause of dementia and an enormous medical, social and economic challenge to Europe. Several lines of evidence point to accumulation of beta-amyloid peptide (Aß) in the brain as the key pathologic event in the disease. There is growing evidence that ...
Voir le projet
7
Participants partenaires
TERMINÉ
NANOPARTICLES FOR THERAPY AND DIAGNOSIS OF ALZHEIMER DISEASE (NAD)
Date du début: 1 sept. 2008, Date de fin: 31 août 2013,
The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is imperative. It is known that β-amyloid (Aβ) peptide plays a central role in neurodegeneration. In AD brain, Aβ is released in a soluble form that progressively becomes insoluble forming aggregates; extracellular plaques mainly composed of Aβ are a hallmark of po ...
Voir le projet
19
Participants partenaires
TERMINÉ
SUstainable PROduction of GALanthamine by both in vitro and agricultural crops of highly galanthamine-containing plants (SUPROGAL)
Date du début: 1 févr. 2009, Date de fin: 31 mars 2011,
...mily Amaryllidaceae, mainly belonging to the genus Galanthus, Leucojum and Narcissus. Owing to its acetylcholinesterase inhibitory activity, galanthamine is used and marketed for the treatment of the Alzheimer’s disease, among others. Although it is obtained by organic synthesis, galanthamine is also being extracted from natural sources. Both Galanthus and Leucojum plants are very widespread in th ...
Voir le projet
7
Participants partenaires
TERMINÉ
Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES)
Date du début: 1 févr. 2010, Date de fin: 31 janv. 2015,
...ic factors. 4 major groups of chronic conditions and disabilities will be studied: (i) cancer; (ii) diabetes and cardiovascular diseases; (iii) fractures and osteoporosis; (iv) cognitive function and Alzheimer disease. Information on other conditions and disabilities (e.g., eye diseases, chronic respiratory conditions) will be also collected if available. Mortality will be assessed in terms of age ...
Voir le projet
17
Participants partenaires
TERMINÉ
Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in the early clinical development (PHARMA-COG)
Date du début: 1 janv. 2010, Date de fin: 31 déc. 2015,
...al objective is to improve the detection and selection of new drugs candidates within a shorter teim-frame.Our consortium gathers 13 academics and clinicians, 8 SMEs, 1 European patient organization (Alzheimer Europe) as well as 1 regulatory body (EMEA), coming form six different EU Members States. Excellence Centres gather representatives of the different sectors: biomarkers (proteomics, transcr ...
Voir le projet
38
Participants partenaires
TERMINÉ
Effects of systemic annonacin exposure in transgenic mice expressing normal or mutant human tau protein: role of environment-gene interactions in neuro- degeneration (TAU-ANNONACIN)
Date du début: 1 mai 2009, Date de fin: 30 avr. 2010,
...d may also increase our understanding of physiopathogenic mechanisms of major neurodegenerative diseases where a gene-environm ent interaction appears to play a role as is the case of Parkinson's and Alzheimer's diseases. The proposed research project has emerged from a consortium of three groups in Europe (Germany, France, Guadeloupe) in cooperation with an experienced researcher from a developin ...
Voir le projet
1
Participant partenaire
TERMINÉ
A WORLDWIDE E-INFRASTRUCTURE FOR COMPUTATIONAL NEUROSCIENTISTS (outGRID) (outGRID)
Date du début: 1 nov. 2009, Date de fin: 31 juil. 2012,
...itude for channelling towards interoperability. Interoperability of neuGRID with LONI is facilitated by (i) the database structure of neuGRID being the same of LONI, i.e. that of the North American Alzheimer's Disease Neuroimaging Initiative (ADNI), (ii) an ultra broad band connection links Europe to US (GTRN) and (iii) neuGRID may adopt LONI's workflow authoring system for algorithm pipelining.ou ...
Voir le projet
6
Participants partenaires
TERMINÉ
"Membrane-active peptides across disciplines and continents: An integrated approach to find new strategies to fight bacteria, dengue virus and neurodegeneration." (MEMPEPACROSS)
Date du début: 1 févr. 2010, Date de fin: 31 janv. 2014,
...ndidates for new generations of drugs to fight highly threatening antibiotic-resistant strains of pathogens. 3) Peptide-membrane interactions are also relevant for neurodegenerative diseases, such as Alzheimer disease. The identification of the conditions necessary for the triggering of the disease-inducing protein aggregation and the search for strategies to inhibit these processes are the key-as ...
Voir le projet
3
Participants partenaires
TERMINÉ
Genomic variations underlying common behavior diseases and cognition trait in human populations (ADAMS)
Date du début: 1 oct. 2009, Date de fin: 30 sept. 2012,
"The subject of the proposal is the search and analysis of genomic variations underlying Alzheimer's disease (AD), alcoholism and schizophrenia – wide-spread diseases in human populations. Schizophrenia and alcoholism are common forms of behavior pathology and disability in adult life. AD is a most common form of dementia in human populations. Though the genomic variations presumably associated wi ...
Voir le projet
12
Participants partenaires
TERMINÉ
Evolving Probabilistic Spiking Neural Networks for Spatio-Temporal Pattern Recognition (EvoSpike)
Date du début: 1 juin 2011, Date de fin: 31 mai 2012,
...analysis; associative memories; neurogenetic cognitive systems. Further applications of the epCNGM are expected to be developed for modelling brain data related to neurodegenerative diseases, such as Alzheimer’s disease. Knowledge will be transferred from the visiting researcher Prof. Kasabov to INI and Europe.
Voir le projet
1
Participant partenaire
TERMINÉ
Coordination Action in support of the implementation of a Joint Programming Initiative for Combating Neurodegenerative Diseases, in particular Alzheimer’s disease (JUMPAHEAD)
Date du début: 1 sept. 2010, Date de fin: 31 août 2014,
The objective of the Coordination Action JUMPAHEAD is to support the implementation of the pilot Joint Programming Initiative on combating neurodegenerative diseases, in particular Alzheimer’s disease (JPND).Neurodegenerative disorders are incurable and debilitating conditions that result in progressive degeneration or death of nerve cells. Of these, the dementias are responsible for the greatest ...
Voir le projet
13
Participants partenaires
TERMINÉ
Linking research organisations in the fields of Tissue Engineering and Regenerative Medicine through European cooperation between regional research clusters (TERM)
Date du début: 1 oct. 2010, Date de fin: 30 sept. 2013,
"The development of innovative 'Advanced Therapies' offers new approaches to tackle major diseases such as cancer, diabetes, Alzheimer or Parkinson. The progress made in the fields of 'Tissue Engineering' and 'Regenerative Medicine' (TERM) promises to deliver long awaited new solutions. They are recognized as potential sources for medical progress and significant economic growth where Europe shoul ...
Voir le projet